Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SIM1

SIM1

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Oligopeptide derivative based on novel coronavirus spike protein SIM site and application thereof
Applicant: UNIV FUDANPriority: 2025
CN
Screening method for small molecular compounds against KSHV/EBV related tumors based on SIM target and application of small molecular compounds
Applicant: UNIV FUDANPriority: 2018
CN
SIMMPYRAs: Novel Drugs for Triple Negative Breast Cancer
Applicant: SIMMARON RSEARCH INCPriority: 2025
US
Oligopeptide derivative based on lysosomal membrane protein 2A and application thereof
Applicant: UNIV FUDANPriority: 2024
CN